Pain and quality of life in postmenopausal osteoporotic  women without vertebral fractures: Vertebral kırığı olmayan postmenopozal osteoporozlu kadınlarda ağrı ve yaşam  kalitesi

Yeşim Garip; Filiz  Eser; Selim  Sayın; Hatice Bodur; Mehtap  Çavuşoğlu

doi:10.5455/GMJ-30-172357

Authors

Yeşim Garip Department of Physical Medicine and Rehabilitation, Ankara Basak Medical Center
Filiz Eser Numune Training and Research Hospital, Physical Medicine and Rehabilitation, Ankara
Selim Sayın Numune Training and Research Hospital, Physical Medicine and Rehabilitation
Hatice Bodur Numune Training and Research Hospital, Physical Medicine and Rehabilitation
Mehtap Çavuşoğlu Numune Training and ResearchHospital, Radiology

DOI:

https://doi.org/10.5455/GMJ-30-172357

Keywords:

Osteoporosis, pain, quality of life

Abstract

Our study aimed to evaluate severity of pain and quality of life in terms of physical, social and emotional functions among the osteoporotic women without vertebral fractures. A total of 40 postmenopausal osteoporotic women without vertebral fractures and 40 age-matched controls were included in the study. Dual-energy x-ray absorptiometry (DEXA) values at lumbar spine (L2-4) and femoral neck, performed in our hospital in the last 6 months (retrospective data) were recorded. Quality of life was assessed with Nottingham Health Profile (NHP) and Assessment of Health-Related Quality of Life in Osteoporosis (ECOS-16). Severity of pain was measured with Visual Analog Scale (VAS). ECOS-16, VAS scores and pain, physical mobility, energy and sleep subscores of NHP were found as higher in the patient group than in the controls (p<0.05). Bone mineral density (BMD) lumbar spine and femoral neck values were found to be negatively correlated with VAS, ECOS-16, and energy, pain, physical mobility, and sleep subgroups of NHP (p<0.05). Pain and deterioration in quality of life in the osteoporotic women should be taken into consideration regardless of presence of vertebral fractures. A better understanding of pain mechanisms in postmenopausal osteoporosis will help us find more effective treatment strategies.

Metrics

Metrics Loading ...

References

Ozgen M, Cosan DT, Doganer F, Soyocak A, Armagan O, Gunes HV, et al. Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women. Clinics (Sao Paulo) 2012;67(11):1299-302

Garg N, Kumar A, Pawan G. Prevalence of osteoporosis in a rural population of Muzaffarnagar district. JIAMC 2012;13(3):185-8

Caliri A, De Filippis L,Bagnato GL, Bagnato GF. Osteoporotic fractures: mortality and quality of life. Panminerva Med 2007;49(1):21-7

Borgström F, Sobocki P, Ström O, Jönsson B. The societal burden of osteoporosis in Sweden. Bone 2007;40(6):1602-9

Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL).Qual Life Res1993; 2(2):153-9

Pamuk G, Kutlu R, Civi S. Evaluation of quality of life inpostmenopausal women with and without osteoporosis using the QUALEFFO-41 scale. Turk J Phys Med Rehabil 2014; 60:139-46

Badia X, Prieto L, Roset M, Díez-Pérez A. Development of the ECOS-16 clinical questionnaire for the assessment of the quality of life in patients with osteoporosis. Med Clin (Barc) 2000;114 Suppl 3:68-75

Badia X, Díez-Pérez A, Lahoz R, Lizán L, Nogués X, Iborra J. The ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis. Health Qual Life Outcomes 2004;2:41

Yilmaz F, Dogu B, Sahin F, Sahin T, Kuran B. Reliability and validity of the Turkish version of the ECOS 16 questionnaire in postmenopausal osteoporosis. Eur J Phys Rehabil Med 2009;45(4):521-6

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.World Health Organ Tech Rep Ser1994;843:1-129

Kucukdeveci AA, Mc Kenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 2000; 23(1):31-38

Price DD, McGrath P, Rafii A. Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17(1):45-56

Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.J Bone Miner Res2000; 15(7):1384-92.

Abourazzak FE, Allali F, Rostom S, Hmamouchi I, Ichchou L, El Mansouri L, et al. Factors influencing quality of life in Moroccan postmenopausal women with osteoporotic vertebral fracture assessed by ECOS 16 questionnaire.Health Qual Life Outcomes 2009; 7:23

Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 2007; 34(7):1551-60

Jahelka B, Dorner T, Terkula R, Quittan M, Bröll H, Erlacher L. Health-related quality of life in patients with osteopenia or osteoporosis with and without fractures in a geriatric rehabilitation department. Wien Med Wochenschr 2009;159(9-10):235-40

Paker N, Bugdaycı D, Dere D, Tekdos D, Erbil E, Dere C. Relationship between bone density and quality of life in postmenopausal osteoporosis. Turkish Journal of Geriatrics 2012; 15(1):19-23

Adıguzel D, Gunduz HO, Bodur H, Yucel M. Quality of life in osteoporosis. Turkish Journal of Rheumatology 2000; 15: 173-9

Altindag O, Altindag A, Soran N, Demirkol A. Quality of life and depression in postmenopausal women with osteoporosis. Turk J Phys Med Rehabil 2007; 53:61-4

Yılmaz H, Erkin G, Polat HAD, Kucuksen S, Salli A, Ugurlu H. Quality of life in osteoporosis: a controlled study. Turk Osteoporoz Dergisi 2012; 18:47-52

Lee KM, Chung CY, Kwon SS, Kim TG, Lee IH, Jung KJ, Park JW, et al.Bone mineral density is not associated with musculoskeletal pain in postmenopausal Korean women aged ≥50 years. Clin Rheumatol 2014 Oct 7 [Epub ahead of print

Fujita T, Fujii Y, Munezane H, Ohue M, Takagi Y. Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis. J Bone Miner Metab 2010; 28(4):477-84.

Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis. Calcif Tissue Int 2012;90(4):279-85.